Heart cavity prosthesis and related heart assistance system
By designing the inner and outer elastic membranes and variable connecting elements of the heart cavity prosthesis, simulating the physiological morphology and operation of the heart cavity, the reflux, non-physiological flow and invasive problems of the existing cardiac assisted system are solved, and a more physiological hemodynamic is achieved. Learn and lower cost treatment options.
Patent Information
- Application Number
- CN202410951107.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2019-07-12
- Filing Date
- 2020-07-13
- Publication Date
- 2024-11-15
AI Technical Summary
The existing cardiac assistive systems, such as axial flow ventricular assistive devices, have problems such as reflux, over-inhalation, irreversible implantation damage, non-physiological flow and thrombosis, and are unable to effectively adapt to changes in sinus rhythm and peripheral circulation, and are highly invasive. , affects heart health.
A heart cavity prosthesis is designed, including an inner elastic membrane and an outer elastic membrane, connected by multiple main variable connecting elements to form a variable volume main gap, simulating the physiological morphology and operation of the heart cavity, using electrical and/or Electromagnetic control enables dynamic changes in volume and pressure, adapts to different environments, and generates physiological pulsation flow.
Significantly increase treatment options for patients with severe heart failure, provide more physiological hemodynamic properties, reduce device size and weight, reduce energy consumption, and simplify manufacturing processes and reduce costs.
Smart Images

Figure CN118949260A_ABST
Abstract
Description
[0001] Divisional application
[0002] This application is a divisional application of application number 202080050774.9, application date July 13, 2020, and titled “Cardiac Chamber Prosthesis and Related Heart Assist System”. Technical Field
[0003] The present invention relates to a cardiac chamber prosthesis selected from the left ventricle, the left atrium, the right ventricle and the right atrium, which can have a physiological morphology in a simple, adaptable, effective and reliable manner and operate according to operations that best suit its physiological characteristics. The present invention also relates to a cardiac chamber prosthesis assembly having two or more such cardiac chamber prostheses, and to a cardiac assist system provided with such a cardiac chamber prosthesis or such a cardiac chamber prosthesis assembly. In addition, the cardiac chamber prosthesis according to the present invention has a reduced size and weight, making it easy to implant and control the cardiac chamber prosthesis in a cardiac assist system that requires reduced energy consumption, thereby significantly increasing the treatment options for patients with severe heart failure and obtaining better treatment effects. In addition, the cardiac chamber prosthesis and the related cardiac assist system according to the present invention are simple to manufacture and have low cost. Background Art
[0004] As is well known, the heart is a muscle that pumps blood through the body: the right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, where the blood is enriched with oxygen and carbon dioxide is removed from the blood, while the left side of the heart receives oxygenated blood returning from the lungs and pumps the oxygenated blood to the body, where it provides oxygen and nutrients to the cells.
[0005] Reference Figure 1 As can be seen, the heart has four chambers, namely, two upper atria and two lower ventricles, namely: right atrium 10, left atrium 20, right ventricle 30 and left ventricle 40. Atria 10 and 30 are receiving chambers, and ventricles 30 and 40 are pumping chambers.
[0006] In addition, the heart has four heart valves, namely: the tricuspid valve 50 disposed between the right atrium 10 and the right ventricle 30; the pulmonary valve 60 disposed between the right ventricle 30 and the pulmonary artery 110; the mitral valve 70 disposed between the left atrium 20 and the left ventricle 40; and the aortic valve 80 disposed between the left ventricle 40 and the aorta 100. The function of the heart valves is to ensure that blood flows through the heart in the correct direction (as shown by the dotted arrows). In particular, deoxygenated blood is pumped from the right ventricle 30 into the pulmonary artery 110 and thereby into the lungs. Similarly, oxygenated blood is pumped from the left ventricle 40 into the aorta 100 and thereby through the body. In addition, the superior vena cava 120 and the inferior vena cava 125 deliver deoxygenated blood from the upper and lower body to the right atrium 10, respectively, while the pulmonary vein 130 delivers oxygenated blood from the lungs to the left atrium 20.
[0007] In more detail, during the systole of a cardiac chamber, the heart assumes a configuration of muscular contraction, wherein the cardiac chamber in question contracts and empties of blood. Figure 1 b), only the atria 10 and 20 contract, the tricuspid valve 50 and the mitral valve 70 open, while the pulmonary valve 60 and the aortic valve 80 close, and blood is transferred from the atria 10 and 20 to the ventricles 30 and 40 respectively; during ventricular contraction ( Figure 1 In FIG. 1 , only the ventricles 30 and 40 contract, the tricuspid valve 50 and the mitral valve 70 close, the pulmonary valve 60 and the aortic valve 80 open, and blood is transferred from the ventricles 30 and 40 to the pulmonary artery 110 and the aorta 100, respectively.
[0008] Similarly, during the diastolic phase of the heart chamber, the heart assumes a muscularly relaxed configuration, wherein the chamber in question widens and fills with blood. Figure 1 a), the atria 10 and 20 expand (early before atrial contraction), the tricuspid valve 50 and the mitral valve 70 are closed, and the blood from the superior vena cava 120 and the inferior vena cava 125 and the pulmonary vein 130 fills the atria 10 and 20 respectively; in ventricular diastole ( Figure 1 b), the ventricles 30 and 40 dilate (early before the ventricles contract) until the ventricles 30 and 40 reach a maximum volume also referred to as the end-diastolic volume, the pulmonary valve 60 and the aortic valve 80 close, and blood from the atria 10 and 20 fills the ventricles 30 and 40, respectively. In particular, atrial contraction occurs in correspondence with ventricular diastole, and atrial diastole occurs in correspondence with ventricular contraction.
[0009] In other words, atrial and ventricular contraction and atrial and ventricular relaxation in sinus rhythm (ie, in healthy human physiology) are synchronized according to precise times that allow the heart to reoxygenate deoxygenated blood from the body by pumping it toward the lungs and then through the body.
[0010] Some diseases of the heart can reduce the heart's ability to pump. When the heart cannot pump blood properly, fluid can accumulate in the lungs and other parts of the body. Symptoms of heart failure often stem from the heart's inability to provide adequate blood flow to the body's vital organs. In such cases, a heart assist system may be needed when medicines and other surgical methods are not enough to resolve heart failure.
[0011] Among the prior art heart assist systems, a widely used solution is the axial flow ventricular assist device (VAD) which includes a mechanical pump and has significantly increased the treatment options for patients with severe heart failure. According to documents WO 89 / 07427A1, WO 99 / 49912A1, US2018 / 0303991 A1 and WO 2018 / 078370 A1, and by Ootaki Y. et al. in "Phasic coronary blood flow pattern during a continuous flow left ventricular assist support", Eur. J. of Cardio-thorac. Surg. 28 (2005) 711-16, by Radovancevic B. et al. in "End-organ Function in Patients on Long-term Circulatory Support With Continuous-or Pulsatile-flow Assist Devices", J. of Heart and Lung Transp. 2007, 815-18, by Frazier OH et al. in "Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation”, J.Thorac.Cardiovasc.Surg.2001,122:1186-95, by Letsou GV et al. in “Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months”, Ann.Thorac.Surg.2003;76:1167-70, by Thalmann M. et al. in “Physiology of continuous blood flow in recipients of rotary cardiac assist devices (”, J.Heart Lung Transplant 2005;24:237-45, by Thohan V.et al.Such VAD devices are described by R. et al. in “Cellular andhemodynamics responses of failing myocardium to continuous flow mechanicalcirculatory support using the DeBakey–Noon left ventricular assist device: a comparative analysis with pulsatile-type devices”, J. Heart Lung Transplant 2005; 24: 566-75 and by Hetzer R. et al. in “First experiences with a novel magnetically suspended axial flow left ventricular assist device”, Eur. J. Cardiothorac. Surg. 2004; 25: 964-70, for example the Jarvik device available from the American company Jarvik Heart Ltd. and the DeBakey device available from the American company MicroMed Technology, Ltd. .
[0012] VAD devices are based on rotary pumps, which were developed to address some of the issues with previous pulsatile devices, such as size and complexity, difficulty with implantation, and adverse events (e.g., perioperative bleeding, infection, thrombosis, and device failure). The miniature implantable pump of a VAD device provides continuous flow, rather than pulsatile flow, by using an electromagnetic mechanism consisting of a rotor with impeller blades. Current non-pulsatile axial flow pumps tend to have a compact design, use a single moving part, and have low energy requirements. For example, the Jarvik device is configured to be implanted within the body of the left ventricle, so it does not require an inflow cannula. Long-term implantation of rotary VAD devices for the left ventricle is increasingly used to treat patients with end-stage heart failure.
[0013] However, currently available VAD devices also suffer from some disadvantages.
[0014] First, the rotary pump provided with the VAD device operates at a speed that must be carefully adjusted to avoid backflow and over-suction. In fact, when the pump speed (rpm) is set to too low a value, backflow (regurgitation) may occur, causing blood to return from the aorta 100 through the pump to the left ventricle 40, and when the pump attempts to extract more blood than is available in the left ventricle 40, over-suction may occur due to the high speed of the pump. Suction can cause ventricular collapse of the left ventricle 40, which can cause chest pain and heart tissue damage. Therefore, the pump flow, which is mainly speed-dependent, heart rate-dependent, and cannot be regulated in a pulsatile manner, cannot physiologically conform to sinus rhythm and cannot follow peripheral circulation changes, resulting in an inability to adapt to cardiac output during use. In addition, the implantation of such a device is extremely invasive and causes irreversible damage to the heart chamber in which the device is implanted, and further exerts pressure on other heart chambers that are stressed by non-natural heart flow.
[0015] The outflow line from the pump is connected to the descending aorta. At high pump speeds, the aortic valve 80 remains closed and the VAD device completely replaces the ventricular heart function. In order to limit the possible formation of thrombi in the aortic valve 80, current VAD systems reduce the speed to 10 seconds per minute, and during this interval, the aortic valve 80 opens again and the pulsating flow is considerable. As the number of revolutions of the rotary pump increases again, the pulsation of the aortic flow decreases, but due to the minimum pressure sufficient to continue to open the aortic valve 80, the pulsation of the aortic flow may not completely disappear. When the aortic valve 80 returns to remain closed, the pressure gradient between the left ventricle 40 and the aorta 100 actually changes with the cardiac cycle, because the pressure changes caused by the opening and closing of the mitral valve 70 (and to a lesser extent by the residual ventricular contraction) are transmitted to the aorta 100 by the pump. The study of the arterial pulse curve allows the understanding of the dicrotic notch in the descending portion of the pressure curve associated with the closure of the mitral valve 70 (the aortic valve 60 continues to close during this 50-second period). In other words, the movement of the myocardium in which a VAD device producing continuous flow is implanted can result in a residual slight pulsation of the circulatory system producing flow.
[0016] In summary, VAD devices produce non-pulsatile and therefore non-physiological flows (ie, not consistent with sinus rhythm) and their hemodynamic properties differ from pulsatile devices.
[0017] As mentioned above, at a given rotational speed, flow through a rotary pump is continuous rather than pulsating as in physiological flow.
[0018] Furthermore, if the pump speed is too high, the typical changes in the waveform morphology of the native arterial pressure tend to disappear and the dicrotic notch (indicating closure of the aortic valve 60) is absent.
[0019] Finally, for VAD devices with rotary pumps, fluctuations in left ventricular pressure are transmitted to the arteries through the VAD device, even when the pump speed is high enough to keep the aortic valve 60 closed. This can have important clinical consequences (e.g., fusion of the cusps of the aortic valve 60 and thrombosis in the ascending aorta), and current studies are aimed at optimizing their use to prevent such complications.
[0020] To overcome these drawbacks, other devices have been developed that enclose the entire organ, such as those described in documents US 2016 / 0317729 A1 and US 2016 / 0346085 A1. US 5139517 A describes an intraventricular in situ pump for use in conjunction with a natural heart.
[0021] However, these devices are also highly invasive and non-selective to the ventricle, which can degenerate and become damaged over time, and do not conform to physiological morphology and may present problems of an electrophysiological nature. Summary of the invention
[0022] Therefore, an object of the present invention is to selectively assist the operation of any cardiac chamber, not just the left ventricle, in a simple, adaptable, efficient and reliable manner to ensure that the cardiac chamber has a physiological morphology and operation that best conforms to the physiological characteristics of the cardiac chamber.
[0023] A particular subject of the invention is a cardiac chamber prosthesis configured to be implanted in a cardiac chamber of a patient, the cardiac chamber being selected from the group consisting of the left ventricle, the left atrium, the right ventricle and the right atrium,
[0024] wherein the cardiac chamber comprises a natural outlet valve and at least one inlet opening selected from the natural inlet valve and one or more outlet ostia of the vena cava or pulmonary vein,
[0025] Among them, cardiac chamber prostheses include:
[0026] an internal elastic membrane having an inner surface delimiting an elastically variable volume, the internal elastic membrane being provided with a first opening delimited by respective first boundaries and with at least one second opening delimited by respective second boundaries,
[0027] a reference supporting elastic membrane structure comprising or consisting of an external elastic membrane provided with a first opening delimited by respective first boundaries and at least one second opening delimited by respective second boundaries, wherein the external elastic membrane is further provided with a plurality of clamps configured to grasp an inner wall of a heart chamber,
[0028] wherein the boundaries of the first openings of the internal elastic membrane and the external elastic membrane are integrally coupled to each other to form an outlet boundary configured to surround and be sutured to a natural outlet valve,
[0029] wherein the boundaries of the second opening of the internal elastic membrane and the external elastic membrane are integrally coupled to each other to form at least one inlet boundary configured to surround and sew onto the at least one inlet opening,
[0030] wherein the internal elastic membrane and the reference supporting elastic membrane structure are connected to each other by means of a plurality of primary variable connection elements,
[0031] Thus, the internal elastic membrane and the reference supporting elastic membrane structure define a main gap between the internal elastic membrane and the reference supporting elastic membrane structure, and the main gap is configured to receive a fluid with a varying amount and / or pressure to dynamically change the volume of the main gap, as well as the elastically variable volume defined by the inner surface of the internal elastic membrane.
[0032] According to another aspect of the present invention, the elastic coefficient of the external elastic membrane may be no greater than, and optionally less than, the elastic coefficient of the internal elastic membrane.
[0033] According to another aspect of the present invention, each of the internal elastic membrane and the external elastic membrane may have a variable elastic coefficient, wherein each of the internal elastic membrane and the external elastic membrane optionally includes two or more regions having respective elastic coefficients.
[0034] According to another aspect of the present invention, the fluid may be a liquid, optionally a blood compatible solution, more optionally a sterile saline solution, or the fluid may be a gas, optionally helium.
[0035] According to another aspect of the present invention, the cardiac chamber prosthesis may further include at least one artificial valve integrally coupled to the outlet boundary or the at least one inlet boundary.
[0036] According to another aspect of the present invention, the main variable connecting elements may be main elastic laces, each of which has an elastic coefficient greater than the elastic coefficient of the external elastic membrane and greater than the elastic coefficient of the internal elastic membrane, wherein the elastic coefficient of the main elastic laces may optionally be variable depending on the area of the internal elastic membrane to which the main elastic laces are connected.
[0037] According to another aspect of the present invention, a cardiac chamber prosthesis may be configured to be housed inside a catheter.
[0038] According to another aspect of the invention, the external elastic membrane and / or the internal elastic membrane may include a radiopaque portion.
[0039] According to another aspect of the invention, the main gap may be configured to be in fluid communication with at least one variable volume elastic bag provided with the prosthesis or in fluid communication with an external pump.
[0040] According to another aspect of the present invention, at least one of the internal elastic membrane and the external elastic membrane may have a discontinuous structure, optionally selected from the following:
[0041] a honeycomb discontinuous structure formed by a plurality of elastic plates connected to each other along elastic joint lines, the elastic plates more optionally being hexagonal elastic plates, wherein, more optionally, the elastic coefficient of the elastic joint lines is greater than the elastic coefficient of the elastic plates, and
[0042] - A discontinuous structure formed by a plurality of elastic polygonal plates connected to each other along elastic joint lines, the elastic polygonal plates more optionally having a pentagonal and / or hexagonal shape, wherein, more optionally, the elastic modulus of the elastic joint lines is greater than the elastic modulus of the elastic polygonal plates.
[0043] According to another aspect of the present invention, the internal elastic membrane and the external elastic membrane may each be provided with a plurality of electrodes configured to electrically and / or electromagnetically polarize the internal elastic membrane and the external elastic membrane, respectively, under the control of an electronic processing unit connected to the electrodes via corresponding control cables.
[0044] According to another aspect of the present invention, the reference supporting elastic membrane structure may further include an intermediate elastic membrane disposed between the outer elastic membrane and the inner elastic membrane, wherein the elastic coefficient of the intermediate elastic membrane is optionally not greater than, and more optionally less than, the elastic coefficients of the outer elastic membrane and the inner elastic membrane,
[0045] wherein the intermediate elastic membrane is provided with a first opening defined by a corresponding first boundary integrally coupled to the boundaries of the first openings of the internal elastic membrane and the external elastic membrane, and at least one second opening defined by a corresponding second boundary integrally coupled to the boundaries of the second openings of the internal elastic membrane and the external elastic membrane,
[0046] wherein the middle elastic membrane and the outer elastic membrane are connected to each other by means of a plurality of secondary variable connection elements, the plurality of secondary variable connection elements are optionally composed of secondary elastic laces, wherein the elastic coefficient of each secondary elastic lace is more optionally greater than the elastic coefficient of the outer elastic membrane and the elastic coefficient of the middle elastic membrane, wherein the elastic coefficient of the secondary elastic lace varies according to the area of the middle elastic membrane to which the secondary elastic lace is connected,
[0047] Thereby, the plurality of primary variable connecting elements connect the inner elastic membrane and the intermediate elastic membrane to each other,
[0048] Thereby, the outer elastic membrane and the intermediate elastic membrane define a secondary gap therebetween, the secondary gap being configured to receive a fluid, the fluid optionally consisting of a liquid, more optionally consisting of a blood-compatible solution, more optionally consisting of a sterile saline solution, or the fluid consisting of a gas, optionally consisting of helium.
[0049] According to another aspect of the present invention, the secondary gap can be configured to receive the fluid having a varying amount and / or pressure to dynamically change the volume of the secondary gap, wherein the secondary gap is optionally configured to be fluidically connected to at least one variable volume elastic bag provided in the prosthesis or to an external pump fluid.
[0050] According to another aspect of the present invention, the intermediate elastic film may have a discontinuous structure, optionally selected from the following:
[0051] a honeycomb discontinuous structure formed by a plurality of elastic plates connected to each other along elastic joint lines, the elastic plates more optionally being hexagonal elastic plates, wherein, more optionally, the elastic coefficient of the elastic joint lines is greater than the elastic coefficient of the elastic plates, and
[0052] - A discontinuous structure formed by a plurality of elastic polygonal plates connected to each other along elastic joint lines, the elastic polygonal plates more optionally having a pentagonal and / or hexagonal shape, wherein, more optionally, the elastic modulus of the elastic joint lines is greater than the elastic modulus of the elastic polygonal plates.
[0053] According to another aspect of the invention, the intermediate elastic membrane may be provided with a plurality of electrodes configured to electrically and / or electromagnetically polarize the intermediate elastic membrane under control of the electronic processing unit connected to the electrodes by respective one or more control cables.
[0054] According to another aspect of the present invention, a cardiac chamber prosthesis may be configured to be implanted:
[0055] - in the left ventricle, whereby the outlet border is an aortic border configured to surround and suture onto a native aortic valve and the at least one inlet border consists of a mitral valve border configured to surround and suture onto a native mitral valve, or
[0056] - in the left atrium, whereby the outlet border is a mitral valve border configured to surround and suture to a native mitral valve, and the at least one inlet border is comprised of one or more pulmonary vein borders configured to surround and suture correspondingly to the respective one or more outlet ostia of a pulmonary vein, or
[0057] - in the right ventricle, whereby the outlet border is a pulmonary valve border configured to surround and suture onto a native pulmonary valve and the at least one inlet border consists of a tricuspid valve border configured to surround and suture onto a native tricuspid valve, or
[0058] - in the right atrium, whereby the outlet border is a tricuspid valve border configured to surround and suture to a native tricuspid valve, and the at least one inlet border is comprised of one or more vena cava borders configured to surround and suture correspondingly to one or more outlet ostia of the vena cava.
[0059] A specific subject of the present invention is also a cardiac chamber prosthesis assembly, which comprises two to four cardiac chamber prostheses as described above, wherein the cardiac chamber prostheses are configured to be implanted in two or more corresponding cardiac chambers of a patient.
[0060] According to another aspect of the present invention, the cardiac chamber prosthesis may include or consist of two cardiac chamber prostheses associated with each other, the two cardiac chamber prostheses being configured to be implanted in the left ventricle and the left atrium, or in the right ventricle and in the right atrium, wherein the main gaps of the two associated cardiac chamber prostheses are fluidically connected to each other via a connecting pipe, whereby, through the displacement of the fluid between the main gaps of the two associated cardiac chamber prostheses, the volume of the main gap of one of the two associated cardiac chamber prostheses is configured to increase when the volume of the main gap of the other of the two associated cardiac chamber prostheses decreases, and to decrease when the volume of the main gap of the other of the two associated cardiac chamber prostheses increases.
[0061] A particular subject of the invention is also a heart assist system comprising:
[0062] - a cardiac chamber prosthesis or a cardiac chamber prosthesis component as described above,
[0063] - at least one pump and / or electronic processing unit configured to control the amount and / or pressure of the fluid admitted in the main space of the cardiac chamber prosthesis of the cardiac chamber prosthesis or of the cardiac chamber prosthesis assembly so as to dynamically change the volume of the main space of the cardiac chamber prosthesis of the cardiac chamber prosthesis or of the cardiac chamber prosthesis assembly.
[0064] The cardiac chamber prosthesis and related components according to the present invention allow to assist the operation of any cardiac chamber (or two or more cardiac chambers) in a physiological way and can also be adapted to different environments due to electrical and / or electromagnetic and / or pneumatic control.
[0065] In particular, the cardiac chamber prosthesis, related components and related cardiac assist systems according to the present invention significantly increase the treatment options for patients with severe heart failure. In fact, the cardiac assist system according to the present invention is capable of generating pulsating and physiological flows, whose hemodynamic characteristics are different from the continuous hemodynamic characteristics obtainable using a VAD device based on a rotary pump. At a given activation speed, the cardiac chamber prosthesis and related components according to the present invention operate in a variable and adaptable manner, and the cardiac chamber prosthesis and related components according to the present invention are sensitive to the pressure gradient passing through the cardiac chamber prosthesis and related components (for example, in the case of application to the left ventricle 40, the gradient is the gradient between the pressure in the aorta 100 and the pressure in the left ventricle 40 during ventricular contraction, and the gradient is the gradient between the pressure in the left atrium 20 and the pressure in the left ventricle 40 during atrial contraction). Moreover, the waveform of the arterial pressure obtained conforms to the physiological waveform of a human heart in which a dicrotic notch is present (i.e., the aortic valve 80 is closed).
[0066] Furthermore, the cardiac chamber prosthesis, the related components and the related cardiac assist system according to the invention have reduced size and weight, are easy to implant and control and require reduced energy consumption.
[0067] Finally, the cardiac chamber prosthesis, related components and related cardiac assist systems according to the present invention are simple to manufacture and have low cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0068] The invention will now be described by way of illustration and not limitation, according to a preferred embodiment of the invention, with particular reference to the figures of the accompanying drawings, in which:
[0069] Figure 1 A schematic cross-sectional view of a heart is shown;
[0070] Figure 2 shows a schematic perspective view of a first embodiment of a prosthesis according to the invention, with a portion thereof removed;
[0071] Figure 3 Shown implanted Figure 2 A schematic cross-sectional view of a prosthetic heart;
[0072] Figure 4 Shows Figure 3 Schematic front view of a patient with the heart visible;
[0073] FIG. 5 shows a schematic perspective view of a second embodiment of a prosthesis according to the invention, with a portion thereof removed ( Figure 5a ) and its enlarged stereogram ( Figure 5b );
[0074] Figure 6shows a schematic cross-sectional view of a heart in which a third embodiment of a prosthesis according to the invention has been implanted;
[0075] Figure 7 Shows Figure 6 Schematic front view of a patient with the heart visible;
[0076] Figure 8 shows a schematic cross-sectional view of a heart in which a fourth embodiment of a prosthesis according to the invention has been implanted;
[0077] Fig. 9 A schematic cross-sectional view showing a heart implanted with a first embodiment of a cardiac chamber prosthesis assembly according to the present invention;
[0078] Fig.10 A schematic cross-sectional view showing a heart implanted with a second embodiment of a cardiac chamber prosthesis assembly according to the present invention;
[0079] Fig.11 A schematic cross-sectional view showing a heart implanted with a third embodiment of a cardiac chamber prosthesis assembly according to the present invention; and
[0080] Fig.12 A schematic cross-sectional view of a heart in which a fourth embodiment of a cardiac chamber prosthesis assembly according to the present invention is implanted is shown.
[0081] In the drawings, the same reference numerals will be used for the same elements. DETAILED DESCRIPTION
[0082] Reference Figure 2 and Figure 3 , it can be observed that according to a first embodiment of the prosthesis according to the invention, the prosthesis is intended for the left ventricle, and is therefore a left ventricular prosthesis. The left ventricular prosthesis comprises an external elastic membrane 200 and an internal elastic membrane 250, each provided with a first opening and a second opening. The boundaries of the first opening of the external elastic membrane 200 and the internal elastic membrane 250 are integrally coupled to each other to form an aortic boundary 285 defining the aortic opening 280; the boundaries of the second opening of the external elastic membrane 200 and the internal elastic membrane 250 are integrally coupled to each other to form a mitral valve boundary 275 defining the mitral valve opening 270. Advantageously, the boundaries of the first opening of the external elastic membrane 200 and the internal elastic membrane 250 are electrically welded to each other to form the aortic boundary 285; similarly, the boundaries of the second opening of the external elastic membrane 200 and the internal elastic membrane 250 are electrically welded to each other to form the mitral valve boundary 275.
[0083] The external elastic membrane 200 and the internal elastic membrane 250 are elastically connected to each other by means of a plurality of elastic ligaments 290, each of which has two ends integrally connected to the inner surface 204 of the external elastic membrane 200 and the outer surface 252 of the internal elastic membrane 250, respectively. Each elastic ligament 290 is configured to be elastically stretched when subjected to a stress that causes its ends to move away from each other starting from a rest configuration. The outer surface 202 of the external elastic membrane 200 is provided with a plurality of conventional hook fasteners 210 (also referred to as clamps), which are similar to those fasteners used to fix a left ventricular volume reduction prosthesis to the inner wall 45 of the left ventricle, and the plurality of conventional hook fasteners 210 are configured to grasp the inner wall 45 of the left ventricle by extending into the tissue of the left ventricle and allow the external elastic membrane 200 to be stably implanted therein, such as Figure 3 shown.
[0084] The morphology of each of the external elastic membrane 200 and the internal elastic membrane 250 is close to the morphology of the inner wall 45 of the left ventricle (in which the prosthesis is intended to be implanted), whereby the external elastic membrane 200 and the internal elastic membrane 250 basically include three regions: a base where the first and second openings are arranged, a ventricular apex, and an intermediate wall connecting the base and the ventricular apex, whereby the intermediate wall is arranged in an intermediate position between the base and the ventricular apex. This allows the external elastic membrane 200 to be fitted to the inner wall of the ventricle like an inner glove, the external elastic membrane 200 being configured to grip the inner wall of the ventricle by means of the clamp 210.
[0085] In this respect, the left ventricular prosthesis, ie the external elastic lamina 200 and its internal elastic lamina 250, can be made in various sizes to adapt to the specific volume of the left ventricle of different patients, which is related to the body surface (BSA - body surface area) of the patient.
[0086] Due to such shapes of the external elastic membrane 200 and the internal elastic membrane 250, the prosthesis is configured to be implanted inside the left ventricle by adapting to the tissue of the left ventricle, and the prosthesis is configured to grasp the inner wall 45 of the left ventricle by the clamp 210. Optionally, the shapes of the side surfaces of both the external elastic membrane 200 and the internal elastic membrane 250 may include two notches (not shown in the figure) without a clamp, and the two notches are configured to receive the anterior and posterior papillary muscles and chordae tendineae of the left ventricle connected to the mitral valve 70 (also not shown in the figure) so that the prosthesis does not interfere with the papillary muscles and chordae tendineae themselves.
[0087] In any case, the morphology of both the external elastic membrane 200 and the internal elastic membrane 250 does not necessarily have to conform perfectly to the morphology of the inner wall 45 of the left ventricle (in which the prosthesis is intended to be implanted), since the elasticity of the external elastic membrane 200 and the internal elastic membrane 250 allows compensating for any morphological differences; in particular, the elasticity of the external elastic membrane 200 allows the external elastic membrane 200 to follow the morphology of the inner wall 45 of the left ventricle that the external elastic membrane 200 grasps by the clamp 210.
[0088] The mitral valve border 275 is configured to surround and be sutured to the native mitral valve 70, and the aortic border 285 is configured to surround and be sutured to the native aortic valve 80. In particular, the mitral valve border 275 operates as an inlet border, the native mitral valve 70 operates as a native inlet valve, at least one inlet opening of the heart chamber includes the native inlet valve, the aortic border 285 operates as an outlet border, and the native aortic valve 80 operates as a native outlet valve.
[0089] The outer and inner elastic membranes 200, 250 and the tether 290 are made of a biocompatible elastic material, optionally a biocompatible elastic polymer material, more optionally polytetrafluoroethylene (also known as ePTFE).
[0090] The clamp 210 is made of a biocompatible metallic material, optionally a shape memory alloy, and more optionally a nickel-titanium shape memory alloy (also known as NITINOL).
[0091] The outer elastic membrane 200 and the inner elastic membrane 250 are elastically connected to each other by means of a plurality of elastic ties 290, and a closed gap 230 is defined between the outer elastic membrane 200 and the inner elastic membrane 250, and the gap 230 has a volume configured to be elastically variable, as will be described in detail later. In particular, the reference supporting elastic membrane structure includes the outer elastic membrane 200, the gap 230 operates as a main gap, and the plurality of elastic ties 290 operate as a plurality of main variable connecting elements.
[0092] Advantageously, the elastic coefficient of the external elastic membrane 200 is not greater than (i.e., less than or equal to), optionally less than (i.e., the elasticity of the external elastic membrane 200 is less) the elastic coefficient of the internal elastic membrane 250. In addition, in order to better simulate the physiological elastic behavior of the left ventricle, the elastic coefficient of the internal elastic membrane 250 can optionally vary according to its region, as will be described in more detail later.
[0093] Advantageously, the elastic coefficient of the elastic tether 290 is greater than the elastic coefficients of the external elastic membrane 200 and the internal elastic membrane 250. Still in order to better simulate the physiological elastic behavior of the left ventricle, the elastic coefficient of the elastic tether 290 can optionally be varied according to the area of the internal elastic membrane 250 to which one end thereof is connected, as will be described in more detail later.
[0094] Figure 2 and Figure 3The left ventricular prosthesis shown can be implanted in the left ventricle by means of a minimally invasive percutaneous implantation, by inserting the left ventricular prosthesis through the aortic valve 80 by means of a catheter containing the compacted prosthesis inside, the catheter optionally having a diameter of 18 French to 24 French, more optionally 18 French to 21 French (wherein French is a unit of measurement of the diameter of the catheter according to the so-called French scale (also known as the Charrière scale), where 1 French = 0,33 mm). This insertion is similar to the insertion currently commonly used for inserting other devices such as artificial aortic valves, mitral valve clips and peripheral stents.
[0095] After insertion into the left ventricle, the prosthesis expands and the grippers 210 provided on the outer surface 202 of the external elastic membrane 200 grasp the inner wall 45 of the left ventricle to stably position the prosthesis in the left ventricle itself. The mitral valve border 275 positioned around the mitral valve 70 is sutured near the mitral valve 70 itself; similarly, the aortic border 285 positioned around the aortic valve 80 is sutured near the aortic valve 80 itself.
[0096] Alternatively, Figure 2 and Figure 3 The left ventricular prosthesis shown can be implanted in the left ventricle by means of non-highly invasive cardiac surgery (e.g., transapical or transclavicular surgery) or by means of invasive cardiac surgery. In this case, after positioning the prosthesis by inserting the clamp 210 into the left ventricular tissue, the prosthesis can also be stabilized by the surgeon by suturing to the inner wall 45 of the left ventricle. Also in this case, the mitral valve border 275 and the aortic border 285 are sutured near the mitral valve 70 and the aortic valve 80, respectively.
[0097] Advantageously, a left ventricular prosthesis according to the present invention includes portions, for example, in the external elastic lamina 200 and / or the internal elastic lamina 250, that are radiopaque and therefore visible by radiography to assist the surgeon during placement of the prosthesis in the left ventricle (for example, the mitral valve boundary 275 and the aortic boundary 285 may be radiopaque).
[0098] The gap 230 defined by the external elastic membrane 200 and the internal elastic membrane 250 is configured to receive a fluid having a varying amount and / or pressure, the fluid being in particular a liquid, such as a blood-compatible solution, for example a sterile saline solution, or the fluid being a gas, for example helium, in order to dynamically change the volume of the gap 230 itself and thus change the elastically variable volume defined by the inner surface 254 of the internal elastic membrane 250.
[0099] To this end, the gap 230 can be accessed through (at least) one access hole provided in the external elastic membrane 200, and after the implantation of the prosthesis in the left ventricle, a conduit 330 is sutured on the hole, wherein the conduit 330 connects the gap 230 to an external (hydraulic or pneumatic) pump 340A. Optionally, the borders of the (at least one) access hole are made of a radiopaque material to allow easy identification of the borders of the access hole to locate the conduit 330; during the insertion of the prosthesis into the left ventricle, the (at least one) access hole is closed to prevent biological material from entering the gap 230. The (at least one) hole can be arranged in any position of the external elastic membrane 200, and therefore, the conduit 330 can cross the corresponding area of the myocardium (and possibly also through the aorta 100). Advantageously, the prosthesis may be provided with a plurality of sealed access holes (or simply have boundaries defining areas of the external elastic membrane 200 that can be removed to form access holes, and the duct 330 may be sutured on these boundaries), and the plurality of sealed access holes may be distributed on the external elastic membrane 200: the surgeon may select the access holes to which the duct 330 is to be sutured based on the positions on the external elastic membrane 200 corresponding to a sufficient area of myocardium, and may open the selected access holes (or remove the areas of the external elastic membrane 200 defined by the selected boundaries to form the access holes), and then suture the duct 330 on the boundaries of the access holes. Alternatively, the surgeon may form a hole passage in any position on the external elastic membrane 200 (corresponding to a sufficient area of myocardium) by removing a region of the external elastic membrane 200 and then suturing the duct 330 on the boundaries of the hole thus formed.
[0100] In order to better understand the present invention, the following describes Figure 2 and Figure 3 The main operating mode of the left ventricular prosthesis is shown. At the end of atrial contraction, the internal elastic lamina 250 expands to the ventricular end-diastolic volume and accommodates oxygenated blood from the left atrium 20. Figure 3 a, it can be observed that, in order to produce an effective ventricular contraction, the pump 340A injects a fluid into the gap 230, for example by introducing a liquid (e.g., a hemocompatible solution) or by blowing a gas (e.g., helium). This causes the volume of the gap 230 to increase and the internal elastic lamina 250 to move away from the external elastic lamina 200, i.e., the internal elastic lamina 250 moves toward the inside of the left ventricle. This causes a consequent increase in the pressure of the internal elastic lamina 250 (i.e., the pressure of the blood contained in the internal elastic lamina 250 increases), and as a result, the mitral valve 70 closes, the aortic valve 80 opens, and the contraction heartbeat ejects blood, also called SV (stroke volume), through the aortic opening 280. In particular, the overall change in the internal volume defined by the internal elastic lamina 250 is, for example, about 80 ml to about 120 ml (normal adult), which is equal to the ejected SV volume; advantageously, the pump 340A is configured to displace a volume of liquid or gas of about 200 ml.
[0101] Reference Figure 3 b, it can be observed that at the end of ventricular contraction, the aortic valve 80 closes and atrial contraction begins, wherein the mitral valve 70 opens and the interior of the internal elastic lamina 250 begins to fill with blood from the left atrium 20 through the mitral valve opening 270. In order to produce effective ventricular relaxation, the pump 340A removes fluid from the gap 230, for example by pumping a liquid (e.g., a blood-compatible solution) or a gas (e.g., helium). This causes the volume of the gap 230 to decrease and the internal elastic lamina 250 to approach the external elastic lamina 200, i.e., the internal elastic lamina 250 moves toward the inner wall 45 of the left ventricle. This keeps the pressure in the internal elastic lamina 250 (i.e., the pressure of the blood contained in the internal elastic lamina 250) at a value lower than the blood pressure in the aorta 100 and the blood pressure in the left atrium 20, thereby keeping the aortic valve 80 closed and the mitral valve 70 open, and promoting blood flow from the left atrium 20 to the interior of the internal elastic lamina 250. Advantageously, the internal elastic lamina 250 can be substantially in contact with the external elastic lamina 200, and the internal elastic lamina 250 and the external elastic lamina 200 can continue to expand as the total volume of the left ventricle increases until a sufficient end-diastolic volume is reached; alternatively, for example, in the case where the ventricular expansion does not significantly damage the myocardium, the internal elastic lamina 250 can expand to reach the ventricular end-diastolic volume without also causing expansion of the external elastic lamina 200.
[0102] At the end of atrial contraction, blood stops flowing from the left atrium 20 into the interior of the internal elastic lamina 250, the mitral valve 70 closes and the aortic valve 80 opens, thereby starting a new cardiac cycle.
[0103] The prosthesis allows obtaining effective emptying of the interior of the internal elastic lamina 250 during ventricular contraction due to the introduction of fluid into the gap 230 , as well as better emptying of the left atrium 20 and effective filling of the interior of the internal elastic lamina 250 during atrial contraction due to the removal of fluid from the gap 230 .
[0104] In other words, the external elastic membrane 200, which is integral with the inner wall 45 of the left ventricle, operates as a pivot for the internal elastic membrane 250, assisting the internal elastic membrane 250 in shifting toward the center of the left ventricle and in the opposite direction toward the inner wall 45 of the left ventricle, thereby allowing a reliable, rapid and efficient change in the volume of the gap 230. Thus, the elastic coefficient of the external elastic membrane 200 is advantageously lower than that of the internal elastic membrane 250, so as to be more rigid than the internal elastic membrane 250 and have limited expansion.
[0105] As described above, in order to better simulate the physiological elastic behavior of the left ventricle, the elastic coefficient of the internal elastic membrane 250 can optionally vary according to the region. In fact, the ventricular apex has a larger displacement than the middle region, and even larger for the regions of the mitral valve 70 and the aortic valve 80, which are the most rigid because the flow line from the first part to the second part is not long. Therefore, optionally, the elastic coefficient of the base of the internal elastic membrane 250 is lower than the elastic coefficient of the middle wall of the internal elastic membrane 250, and the elastic coefficient of the middle wall of the internal elastic membrane 250 is lower than the elastic coefficient of the ventricular apex (with the largest elastic coefficient) of the internal elastic membrane 250. This allows to avoid the formation of potential flow turbulence and energy losses. Possibly, the elastic coefficient of the internal elastic membrane 250 can also vary in a continuous manner (gradually increase) from the base of the internal elastic membrane 250 to the ventricular apex.
[0106] Still in order to better simulate the physiological elastic behavior of the left ventricle, the elastic coefficient of the elastic lace 290 is optionally changed according to the area of the internal elastic membrane 250 to which one of the ends of the elastic lace 290 is connected, that is, the elastic coefficient of the elastic lace 290 connected to the base of the internal elastic membrane 250 is smaller than the elastic coefficient of the elastic lace 290 connected to the middle wall of the internal elastic membrane 250, and the elastic coefficient of the elastic lace 290 connected to the middle wall of the internal elastic membrane 250 is smaller than the elastic coefficient of the elastic lace 290 connected to the ventricular apex (having the largest elastic coefficient) of the internal elastic membrane 250. Possibly, the elastic coefficient of the elastic lace 290 can also change in a continuous manner (increase in steps) from the base of the internal elastic membrane 250 to the ventricular apex.
[0107] like Figure 4 As shown, the pump 340A, together with a possibly rechargeable battery or an accumulator dedicated to its power supply, is housed in a box (or even a backpack) 430 carried by the patient 440, for example attached to a belt 435. A conduit 330 connects the pump 340A housed in the box 430 with the left ventricular prosthesis implanted in the heart 445 of the patient 440. The pump 340A is provided with an electronic processing unit that controls the operation of the pump itself to regulate the expansion and compression of the internal elastic membrane 250 according to the amplitude and speed of the specific BSA of the patient 440 implanted with the prosthesis according to the invention. In this respect, the operation of the pump 340A and therefore the volume changes of the gap 230 can be controlled in a manner similar to what occurs in a pacemaker.
[0108] The heart assist system comprising the left ventricular prosthesis and pump 340A (controlled by an electronic processing unit) can be used as a semi-permanent bridge, i.e., as a temporary support system until a new heart organ is available for transplantation, or as a permanent prosthetic system as an alternative to replacing the entire heart organ.
[0109] A significant advantage offered by the prosthesis according to the invention over prior art solutions is that the patient continues to have a natural heart organ, albeit with its functions reduced and regulated. Also due to the less invasiveness of the prosthesis according to the invention, this allows maintaining or restoring the correct function of other heart chambers that may have begun to have dysfunctions caused by left ventricular dysfunction. As an example, over time, left ventricular dysfunction leads to degeneration and therefore also to pathologies of the left atrium; even if the left ventricle is corrected alone, it is possible to reestablish the proper functioning of the left atrium as well as the right ventricle and therefore the right atrium. In this way, the prosthesis according to the invention allows restoring the rest of an organ that has not yet been completely damaged.
[0110] FIG. 5 shows a second embodiment of a prosthesis according to the invention, which is also intended for use in the left ventricle and is therefore a left ventricular prosthesis. Figure 2 and Figure 3 The difference of the first embodiment shown lies in the configuration of the internal elastic membrane. In particular, while the internal elastic membrane 250 of the first embodiment has a continuous structure, the internal elastic membrane 260 of the second embodiment shown in FIG. 5 has a honeycomb discontinuous structure formed by a plurality of elastic plates 265 (optionally hexagonal elastic plates) connected to each other along elastic joint lines 267.
[0111] Other embodiments of the prosthesis according to the present invention may have an internal elastic membrane having a discontinuous structure different from the structure shown in Figure 5, such as a discontinuous structure formed by multiple elastic polygonal plates (such as pentagons and / or hexagons) connected to each other along elastic joint lines.
[0112] Advantageously, the elastic ties 290 connecting the inner surface 204 of the outer elastic membrane 200 to the outer surface of the inner elastic membrane 260 are fixed to the top end (i.e., vertex) of the elastic plate 265 (coinciding with the end of the elastic joint line 267) forming the honeycomb discontinuous structure (or more generally, fixed to the top end of the elastic polygonal plate forming the discontinuous structure).
[0113] Optionally, the elastic constant of the elastic joint line 267 is greater than the elastic constant of the elastic plate 265; in this case, the minimum volume defined by the internal elastic membrane 260 is always greater than zero, thereby increasing the reliability and efficiency of the operation of the prosthesis.
[0114] Other embodiments of the prosthesis according to the invention may have an external elastic membrane having a discontinuous structure formed by a plurality of elastic plates connected to each other, wherein such a discontinuous structure may have, for example, a honeycomb configuration with hexagonal plates, or a polygonal plate discontinuous structure, for example with pentagonal and / or hexagonal shapes. Advantageously, the elastic ties connecting the inner surface of the external elastic membrane to the outer surface of the internal elastic membrane are fixed to the top ends of the elastic plates forming the discontinuous structure of the external elastic membrane (coinciding with the ends of the elastic joint lines). Furthermore, the external elastic membrane may be perforated. Embodiments having an external elastic membrane comprising a discontinuous structure may be provided with an internal elastic membrane having a continuous or discontinuous structure.
[0115] Reference Figure 6 , it can be observed that a third embodiment of a prosthesis according to the invention is still intended for the left ventricle and is therefore a left ventricular prosthesis. Instead of hydraulic or pneumatic control of the volume delimited by the gap 230 (introduction of fluid into the gap 230 or suction of fluid from the gap 230 by means of a pump 340A), this third embodiment of the prosthesis according to the invention has an outer elastic membrane 205 and an inner elastic membrane 255 each provided with a plurality of optionally electrically insulated electrodes configured to polarize the outer elastic membrane 205 and the inner elastic membrane 255 themselves electrically and / or electromagnetically under the control of an electronic processing unit 345A connected to the electrodes of the outer elastic membrane 205 and the inner elastic membrane 255 by respective control cables 206 and 256.
[0116] The volume change of gap 230 is controlled by the electrical and / or electromagnetic polarity of the external elastic membrane 205 and the internal elastic membrane 255. Figure 6 a), the electronic processing unit 345A controls the electrodes so that the outer elastic membrane 205 and the inner elastic membrane 255 have the same electrical and / or electromagnetic polarity, thereby the outer elastic membrane 205 and the inner elastic membrane 255 repel each other and increase the volume of the gap 230, similar to the reference Figure 3 a causes the contraction heartbeat to eject blood into the aorta 100. During atrial contraction ( Figure 6 b), the electronic processing unit 345A controls the electrodes so that the outer elastic membrane 205 and the inner elastic membrane 255 have opposite electrical and / or electromagnetic polarities, so that the outer elastic membrane 205 and the inner elastic membrane 255 attract each other and reduce the volume of the gap 230 (possibly until it returns to zero), thus similar to the reference Figure 3 b) promotes blood to flow from the left atrium 20 to the interior of the internal elastic lamina 255.
[0117] In this regard, the gap 230 may be filled with a liquid (e.g., a blood-compatible solution) and in fluid communication with at least one variable volume elastic bag (not shown) operating as a liquid reservoir, the elastic bag being positioned inside the myocardium (e.g., near the aortic valve 80 and / or near the mitral valve 70) or outside the myocardium; during atrial contraction, the liquid is displaced from the gap 230 into the elastic bag (which increases the volume of the elastic bag), and during ventricular contraction, the liquid is displaced from the elastic bag into the gap 230 (which decreases the volume of the elastic bag). Instead of or in combination with a liquid, the gap 230 may be filled with a gas (e.g., helium), and since the gap 230 is compressible, the pressure of the gap 230 may be varied from a high value during atrial contraction to a low value during ventricular contraction without necessarily requiring the gap 230 to be in fluid communication with the variable volume elastic bag (in which case the variable volume elastic bag is therefore optional).
[0118] The electronic processing unit 345A can control the electrical and / or electromagnetic polarity of each of the external elastic membrane 205 and the internal elastic membrane 255 in a manner that varies with time and amplitude, depending on the effect of a specific area of the (external or internal) elastic membrane (205 or 255) under consideration. In particular, the electronic processing unit 345A can control the electrodes of the external elastic membrane 205 with the same control signal (also varying with time), or by considering the subdivision of the electrodes into different groups (e.g., a base group including one or more electrodes arranged in the base of the external elastic membrane 205, a middle wall group including one or more electrodes arranged in the middle wall of the external elastic membrane 205, and a ventricular apex group including one or more electrodes arranged in the ventricular apex of the external elastic membrane 205), or by sending a corresponding control signal (also varying with time) to each electrode (wherein, possibly two or more electrodes can receive the same corresponding control signal to each other). Similarly, the electronic processing unit 345A can also control the electrodes of the internal elastic membrane 255 in a similar pattern, i.e., using the same control signal (also varying over time), or using corresponding control signals for different groups into which the electrodes are subdivided (also varying over time), or using corresponding control signals for each electrode (also varying over time). In this regard, the electrode control pattern of the external elastic membrane 205 can be the same as or different from the electrode control pattern of the internal elastic membrane 255.
[0119] The power supply for the electronic processing unit 345A controlling the operation of the prosthesis is via an optionally rechargeable and may be housed in an external box (or even a backpack) carried by the patient (in a manner similar to Figure 4 Alternatively, as shown in Figure 7As shown, similar to conventional pacemakers, the electronic processing unit 345A together with the battery for its power supply can be implanted subcutaneously in a patient 440 having a left ventricular prosthesis implanted in his heart 445. In this respect, the electrodes and therefore the polarity of the external elastic membrane 205 and the internal elastic membrane 255 and the resulting volume change of the gap 230 can be controlled similarly to what occurs in a pacemaker. Also in this case, the electronic processing unit 345A controls the operation of the prosthesis so as to adjust the expansion and compression of the internal elastic membrane 255 with an amplitude and speed suitable for the specific BSA of the patient 440, wherein the prosthesis according to the present invention is implanted, for example, by adjusting the strength of the electrical and / or electromagnetic polarity to cause variable attractive and repulsive forces between the external elastic membrane 205 and the internal elastic membrane 255.
[0120] include Figure 6 The heart assist system of the left ventricular prosthesis and the electronic processing unit 345A that controls the operation of the left ventricular prosthesis may also be used as a semi-permanent bridge or a permanent prosthesis system.
[0121] Figure 6 The left ventricular prosthesis shown is also provided with an artificial aortic valve 530, which is integrally connected to the aortic border 285, which defines the aortic opening 280 of the prosthesis. Such an artificial aortic valve 530 allows to overcome the problems caused by an inadequate or diseased natural aortic valve. In this case, the prosthesis is advantageously implanted using cardiac surgical techniques by opening the natural aortic valve or alternatively by a minimally invasive percutaneous approach or by a non-highly invasive transapical or transclavicular approach. Once implanted, the artificial aortic valve 530 pushes the natural aortic valve to keep the natural aortic valve open, whereby the opening or closing of the aortic opening 280 of the prosthesis depends on the opening of the artificial aortic valve 530 (e.g. Figure 6 a, wherein the artificial aortic valve 530 is open (schematically represented by the raised plate beam 535) or closed (as shown in FIG. Figure 6 b).
[0122] In particular, the artificial aortic valve 530 according to the present invention, which is integrally connected to the aortic border 285 defining the aortic opening 280 of the prosthesis, has better positioning and greater stability than can be obtained with artificial aortic valves of the prior art. In particular, the operation of the artificial aortic valve 530 can also be controlled by specific electrodes distributed on components of the valve itself, which electrodes are configured to cause the valve to open and close by the electrical and / or electromagnetic polarity of these components, wherein the electrodes are in turn controlled by the electronic processing unit 345A. In addition, the artificial aortic valve 530 avoids the problem of residual regurgitation after implantation, which problem may occur in the case of conventional percutaneous artificial aortic valve implantation, also known as TAVI (trans-aortic valve implantation).
[0123] Alternatively or in combination with the artificial aortic valve 530, other embodiments of the prosthesis according to the invention may be provided with an artificial mitral valve. Furthermore, embodiments of the prosthesis according to the invention in which the volume defined by the gap 230 is controlled by a pump that introduces fluid into the gap 230 or draws fluid from the gap 230 may be provided with an artificial mitral valve.
[0124] It should be noted that other embodiments of the prosthesis according to the present invention can be as follows Figure 3 and Figure 4 Hydraulic or pneumatic control is used as shown, or Figure 6 and Figure 7 The use of electrical and / or electromagnetic control is shown, wherein these two types of control cooperate to change the volume defined by the gap 230; in particular, in the case of hydraulic control using a liquid (e.g., a blood-compatible solution), the pump 340A can advantageously replace the at least one variable volume elastic bag (positioned inside or outside the myocardium) that is electrically and / or electromagnetically controlled. Moreover, there can be a single electronic processing unit that controls both the pump 340A and the electrodes of the outer elastic membrane 205 and the inner elastic membrane 255.
[0125] Reference Figure 8 It can be observed that the fourth embodiment of the prosthesis according to the invention is still intended for the left ventricle and is therefore a left ventricular prosthesis intended for patients whose myocardium has pathological characteristics that do not allow the use of the inner wall 45 of the left ventricle in a sufficiently effective and reliable manner, whereby the external elastic membrane 200 integral with the inner wall 45 of the left ventricle cannot operate sufficiently effectively and reliably as a pivot for the internal elastic membrane 250. By way of example and not limitation, this is the case of a patient suffering from dilated cardiomyopathy.
[0126] Figure 8 The left ventricular prosthesis shown is Figure 6 to Figure 7The prosthesis shown is different in that it also includes an intermediate elastic membrane 225 disposed between the external elastic membrane 205 and the internal elastic membrane 255. The intermediate elastic membrane 225 has a shape similar to that of the external elastic membrane 205 and the internal elastic membrane 255, whereby the intermediate elastic membrane 22 is provided with a first opening and a second opening, the boundaries of which are integrally coupled with the boundaries of the first opening and the second opening of the external elastic membrane 205 and the internal elastic membrane 255, respectively, to form an aortic boundary defining the aortic opening of the left ventricular prosthesis (configured to surround and be sutured on the native aortic valve 80) and a mitral valve boundary defining the mitral valve opening of the left ventricular prosthesis (configured to surround and be sutured on the native mitral valve 70). Also in this case, advantageously, the boundaries of the first openings of the external elastic membrane 205, the intermediate elastic membrane 225 and the internal elastic membrane 255 are electrically welded to each other to form the aortic boundary; similarly, the boundaries of the second openings of the external elastic membrane 205, the intermediate elastic membrane 225 and the internal elastic membrane 255 are electrically welded to each other to form the mitral valve boundary.
[0127] Similar to the outer elastic membrane 205 and the inner elastic membrane 255, even the intermediate elastic membrane 225 is provided with a plurality of optionally electrically insulated electrodes, the electrodes being configured to electrically and / or electromagnetically polarize the intermediate elastic membrane 225 itself under the control of an electronic processing unit 345B, which also controls the electrical and / or electromagnetic polarity of the outer elastic membrane 205 and the inner elastic membrane 255 and is connected to the electrodes of the outer elastic membrane 205, the intermediate elastic membrane 225 and the inner elastic membrane 255 by means of corresponding control cables 206, 226 and 256.
[0128] The intermediate elastic membrane 225 is elastically connected to the outer elastic membrane 205 and the inner elastic membrane 255 by means of a plurality of outer elastic laces 290A and a plurality of inner elastic laces 290B, respectively. Each outer elastic lace 290A has two ends integrally coupled to the inner surface of the outer elastic membrane 205 and the outer surface of the intermediate elastic membrane 225 (i.e., the surface facing the outer elastic membrane 205), respectively; similarly, each inner elastic lace 290B has two ends integrally coupled to the outer surface of the inner elastic membrane 255 and the inner surface of the intermediate elastic membrane 225 (i.e., the surface facing the inner elastic membrane 205), respectively. Each inner elastic lace 290B is configured to be elastically stretched from the rest configuration when subjected to stress causing its ends to move away from each other; advantageously, each outer elastic lace 290A is also configured to be elastically stretched from the rest configuration when subjected to stress causing its ends to move away from each other. Optionally, the elastic coefficient of the outer elastic lace 290A is greater than the elastic coefficient of the middle elastic film 225 and the elastic coefficient of the outer elastic film 205; more optionally, the elastic coefficient of the outer elastic lace 290A varies according to the area of the middle elastic film 225 to which the outer elastic lace is connected.
[0129] As described above, the external elastic membrane 205 and the internal elastic membrane 255 are Figure 6 to Figure 7 Similar to those of the illustrated embodiment, the outer surface of the exoelastic membrane 205 is provided with a plurality of conventional clips 210 configured to grip to the inner wall 45 of the left ventricle by extending into the tissue of the left ventricle and allowing the exoelastic membrane 205 to be stably implanted.
[0130] Moreover, like the external elastic membrane 205 and the internal elastic membrane 255, the morphology of the intermediate elastic membrane 225 advantageously approximates the morphology of the inner wall 45 of the left ventricle (in which the prosthesis is intended to be implanted), the intermediate elastic membrane 225 optionally includes two notches configured to receive the anterior and posterior papillary muscles and chordae tendineae of the left ventricle connected to the mitral valve 70, and can be made in various sizes to adapt to the specific volume of the left ventricle of different patients, which is associated with the patient's BSA. In any case, similar to both the external elastic membrane 205 and the internal elastic membrane 255, even the morphology of the intermediate elastic membrane 225 does not necessarily have to completely conform to the morphology of the inner wall 45 of the left ventricle (in which the prosthesis is intended to be implanted), because the elasticity of the intermediate elastic membrane 225 allows compensating for any morphological differences.
[0131] Furthermore, the intermediate elastic membrane 225, as well as the outer and inner elastic membranes 205 and 255, and the outer and inner elastic laces 290A and 290B are made of a biocompatible elastic material, optionally a biocompatible elastic polymer material, more optionally polytetrafluoroethylene (also known as ePTFE).
[0132] The outer elastic membrane 205 and the middle elastic membrane 225 are elastically connected to each other by means of a plurality of outer elastic ties 290A, defining a closed outer gap 230A between the outer elastic membrane 205 and the middle elastic membrane 225, the outer gap 230A having a volume configured to be elastically variable (even though this is not an essential feature of the present invention). The middle elastic membrane 225 and the inner elastic membrane 255 are elastically connected to each other by means of a plurality of inner elastic ties 290B, defining a closed inner gap 230B between the middle elastic membrane 225 and the inner elastic membrane 255, the inner gap 230B having a volume configured to be elastically variable, as will be described in detail later.
[0133] In particular, the reference supporting elastic membrane structure includes an outer elastic membrane 205, an intermediate elastic membrane 225, and a plurality of outer elastic ties 290A. In addition, the inner gap 230B operates as a primary gap, the outer gap 230A operates as a secondary gap, the plurality of inner elastic ties 290B operate as a plurality of primary variable connection elements, and the plurality of outer elastic ties 290A operate as a plurality of secondary variable connection elements.
[0134] The intermediate elastic membrane 225 may have a continuous structure and a discontinuous structure formed by a plurality of elastic plates connected to each other, wherein such a discontinuous structure may have, for example, a honeycomb structure with hexagonal plates, or a discontinuous structure such as with pentagonal and / or hexagonal polygonal plates. Advantageously, the elastic ties connecting the inner surface of the outer elastic membrane to the outer surface of the intermediate elastic membrane and the elastic ties connecting the outer surface of the inner elastic membrane to the inner surface of the intermediate elastic membrane are fixed to the top ends of the elastic plates forming the discontinuous structure of the intermediate elastic membrane (coinciding with the ends of the elastic joint lines). An embodiment having an intermediate elastic membrane including a discontinuous structure may be provided with an inner elastic membrane having a continuous or discontinuous structure and an outer elastic membrane having a continuous or discontinuous structure.
[0135] Also in Figure 8 In the fourth embodiment of the prosthesis shown, similar to Figure 6 As shown, the electronic processing unit 345B controls the electrical and / or electromagnetic polarity of all and each of the outer elastic membrane 205, the intermediate elastic membrane 225, and the inner elastic membrane 255 to change the volume of the inner gap 230B. In particular, the elastic constant of the intermediate elastic membrane 225 is not greater than (i.e., less than or equal to), optionally less than (i.e., the elasticity of the intermediate elastic membrane 225 is less) the elastic constant of the outer elastic membrane 205. This allows the intermediate elastic membrane 225 to operate as a pivot for the inner elastic membrane 255, assisting in the displacement of the inner elastic membrane 255 toward the center of the left ventricle and in the opposite direction toward the inner wall 45 of the left ventricle, thereby allowing a reliable, rapid and efficient overall change of the inner volume defined by the inner elastic membrane 255. In particular, relative to the configuration (optionally a rest configuration) assumed by the intermediate elastic membrane 225 in a substantially static (i.e., constant) reference position, the intermediate elastic membrane 225 is optionally configured to expand only a little relative to the expansion amplitude of the outer elastic membrane 205 and the inner elastic membrane 255, and to be substantially completely uncompressed.
[0136] In this regard, the electronic processing unit 345B controls the electrical and / or electromagnetic polarity of all and each of the external elastic membrane 205, the intermediate elastic membrane 225, and the internal elastic membrane 255 so that the intermediate elastic membrane 225 assumes a substantially static (i.e., constant) position that internally defines the patient's physiological ventricular end-diastolic volume, and so that the internal elastic membrane 255 moves relative to the intermediate elastic membrane 225, thereby cyclically changing the volume of the internal gap 230B. In particular, during atrial contraction (e.g., during atrial contraction), the volume of the internal gap 230B is changed by the internal elastic membrane 255. Figure 8 b), the electronic processing unit 345B controls the electrical and / or electromagnetic polarity of all and each of the outer elastic membrane 205, the middle elastic membrane 225 and the inner elastic membrane 255, so that the inner elastic membrane 255 and the middle elastic membrane 225 attract each other and reduce the volume of the inner gap 230B (optionally) to zero, similar to the reference Figure 3b) causes blood to flow from the left atrium 20 to the interior of the internal elastic lamina 255. During ventricular contraction ( Figure 8 a), the electronic processing unit 345B controls the electrical and / or electromagnetic polarity of all and each of the outer elastic membrane 205, the middle elastic membrane 225 and the inner elastic membrane 255, so that the middle elastic membrane 225 and the inner elastic membrane 255 repel each other and increase the volume of the inner gap 230B, thereby similar to the reference Figure 3 a causes the contraction heartbeat to eject blood into the aorta 100.
[0137] In the first mode of operation, the electronic processing unit 345B maintains the polarity of the intermediate elastic membrane 225 constant and dynamically changes the polarity of the external elastic membrane 205 and the internal elastic membrane 255. In particular, during the cardiac cycle, the electronic processing unit 345B also dynamically changes the polarity of the external elastic membrane 205 to prevent the change in polarity of the internal elastic membrane 255 from causing a displacement of the intermediate elastic membrane 225 relative to a substantially static (i.e., constant) reference position that defines the patient's physiological ventricular end-diastolic volume internally. In other words, in this first mode of operation, the volume of the external gap 230A remains substantially constant.
[0138] Figure 8 Other operating modes of the prosthesis shown in FIG. 340A may have the electronic processing unit 345B also dynamically change the polarity of the intermediate elastic membrane 225, rather than keeping the polarity of the intermediate elastic membrane 225 constant. Even in these other operating modes, the volume of the outer gap 230A may remain substantially constant.
[0139] also, Figure 8 Other modes of operation of the prosthesis shown in can have an electronic processing unit 345B that controls the electrical and / or electromagnetic polarity of all and each of the outer elastic membrane 205, the intermediate elastic membrane 225, and the inner elastic membrane 255 to change the volume of the outer gap 230A in addition to changing the volume of the inner gap 230B.
[0140] Similar to Figure 6The gap 230 of the prosthesis, the inner gap 230B can be filled with a liquid (e.g., a blood-compatible solution) and is in fluid communication with at least one variable volume elastic bag (not shown) operating as a liquid reservoir, the elastic bag can be positioned inside the myocardium (e.g., near the aortic valve 80 and / or near the mitral valve 70) or outside the myocardium; during atrial contraction, the liquid is displaced from the inner gap 230B into the elastic bag (which increases the volume of the elastic bag), and during ventricular contraction, the liquid is displaced from the elastic bag into the inner gap 230B (which decreases the volume of the elastic bag). Instead of or in combination with a liquid, the inner gap 230B can be filled with a gas (e.g., helium), because the inner gap 230B is compressible, the pressure of the inner gap 230B can be changed from a high value during atrial contraction to a low value during ventricular contraction, without requiring the inner gap 230B to be in fluid communication with the variable volume elastic bag (in this case, the variable volume elastic bag is therefore optional).
[0141] In an operating mode in which the volume of the outer gap 230A is kept substantially constant, this may be filled with a predetermined amount of liquid (eg, a hemocompatible solution) or gas (eg, helium).
[0142] exist Figure 8 In other operating modes of the illustrated prosthesis, in which the volume of the outer gap 230A also varies, this may be filled with a liquid (e.g., a blood-compatible solution) and in fluid communication with at least one variable volume elastic bag (not shown) positioned inside the myocardium (e.g., near the aortic valve 80 and / or near the mitral valve 70) or positioned outside the myocardium, possibly coinciding with the at least one variable volume elastic bag with which the inner gap 230B is in fluid communication. Instead of or in combination with a liquid, the outer gap 230A may be filled with a gas (e.g., helium), and since the outer gap 230A is compressible, the outer gap 230A may vary its pressure without necessarily requiring the outer gap 230A to be in fluid communication with a variable volume elastic bag (in which case the variable volume elastic bag is therefore optional).
[0143] A fifth embodiment of a prosthesis according to the invention, still intended for the left ventricle, is Figure 8 The difference shown is that instead of electrically and / or electromagnetically controlling the volume of the inner gap 230B (and possibly the volume of the outer gap 230A) by the polarity of the outer elastic membrane 205, the middle elastic membrane 225, and the inner elastic membrane 255, the volume of the inner gap 230B (and possibly the volume of the outer gap 230A) is changed by hydraulic or pneumatic control by means of a pump (or two pumps) that introduces fluid into the inner gap 230B or draws fluid from the inner gap 230B (and possibly into the outer gap 230A), similar to the method for Figure 25. In this case, the prosthesis may already be provided with (at least) a portion of a conduit for accessing the inner space 230B before implantation, the conduit connecting (at least) a corresponding access hole present on the external elastic membrane 205 with the inner space 230B; during the implantation phase, the surgeon sutures a corresponding conduit on the (optionally radiopaque) border of such an access hole, the conduit together with the conduit portion connecting an external pump with the inner space 230B whose volume change is controlled by the pump.
[0144] It must be pointed out that other embodiments of the prosthesis according to the invention intended for the left ventricle and having an external elastic membrane 205, an intermediate elastic membrane 225 and an internal elastic membrane 255 can use hydraulic or pneumatic control as well as electrical and / or electromagnetic control, wherein these two types of control cooperate in the variation of the volume defined by the inner gap 230B (and possibly the variation of the volume defined by the outer gap 230A).
[0145] Other embodiments of the prosthesis according to the present invention are intended for use in the other three heart chambers, namely the left atrium 20, the right ventricle 30 and one of the right atrium 10, and are similar to those for the prosthesis for use in the left atrium 20, the right ventricle 30 and the right atrium 10. Figures 2 to 8 The illustrated embodiment of the prosthesis is shown; namely:
[0146] - the prosthesis intended for use between the left ventricle 40 and the right ventricle 30 has a first opening and a second opening configured to surround and suture the two natural valves of the cardiac chamber for which they are intended; optionally, the shape of the lateral surface of the elastic membrane of the prosthesis may include three notches without clamps, configured to receive the papillary muscles of the right ventricle connected to the tricuspid valve 50, so as not to allow the prosthesis to interfere with the papillary muscles themselves;
[0147] a prosthesis intended for the left atrium 20 having a first opening configured to surround and be sutured to the native mitral valve 70 and at least one second opening configured to be sutured corresponding to the ostium of at least one corresponding pulmonary vein 130;
[0148] a prosthesis intended for the right atrium 10 having a first opening configured to surround and be sutured to the native tricuspid valve 50 and one or more second openings configured to be sutured corresponding to the superior vena cava 120 and / or the inferior vena cava 125;
[0149] - the prosthesis has two or three membranes elastically connected to each other by means of elastic ties, whereby the prosthesis comprises: an external elastic membrane and an internal elastic membrane, between which the external elastic membrane and the internal elastic membrane define a closed gap having a volume configured to be elastically variable; or an intermediate elastic membrane placed between the external elastic membrane and the internal elastic membrane, which together with the intermediate elastic membrane define a closed outer gap and a closed inner gap having a volume configured to be elastically variable, and wherein the external elastic membrane is configured to be gripped by a clamp up to the inner wall of the heart chamber;
[0150] - the prosthesis has at least one pump configured to perform hydraulic or pneumatic control and / or an electronic processing unit configured to control the electrical and / or electromagnetic polarity of an elastic membrane provided with electrodes to control the volume variation of a variable volume gap with associated cardiac cycles and phases;
[0151] -Similar to Figure 6 The left ventricular prosthesis shown may be provided with at least one artificial valve.
[0152] In particular, the elastic modulus of the elastic membrane of the prosthesis may also differ according to the specific cardiac chamber for which each prosthesis is intended.
[0153] With targeting Figures 2 to 8 The left ventricular prosthesis shown is similar to that illustrated, and the prosthesis according to the invention also intended for use in the other three heart chambers, namely the left atrium 20, the right ventricle 30 and one of the right atrium 10, can be implanted using cardiac surgery techniques or alternatively by minimally invasive percutaneous approaches or by non-highly invasive transapical or transclavicular approaches through specific access to a specific heart chamber. As an example and not limitation, the prosthesis according to the invention intended for use in the right ventricle, and thus as a right ventricular prosthesis, can be implanted using cardiac surgery techniques by opening the tricuspid valve or the pulmonary valve.
[0154] The cardiac chamber prosthesis assembly according to the invention may also be intended for use in more than one cardiac chamber.
[0155] As an example, Fig. 9 A first embodiment of a cardiac chamber prosthesis assembly intended for use with the left ventricle 40 and the left atrium 20 is shown. In particular, the assembly includes a Figure 3 The left ventricular prosthesis shown is configured to be implanted in the left ventricle 40, and is also similar to Figure 3 The illustrated prosthesis is configured as a left atrial prosthesis implanted in the left atrium 20. In particular, Fig. 9The left atrial prosthesis of the illustrated assembly includes an external elastic membrane 600 and an internal elastic membrane 650 elastically connected to each other by means of a plurality of elastic laces 290, the elastic laces 290 defining a closed gap 630 between the external elastic membrane 600 and the internal elastic membrane 650, the gap 630 having a volume configured to be elastically variable, and wherein the external elastic membrane 650 is configured to grasp the inner wall 25 of the left atrium 20 through a plurality of clamps 210. The external elastic membrane 600 and the internal elastic membrane 650 of the left atrial prosthesis are provided with a first opening and a second opening, the boundaries of which are integrally coupled to each other to form a mitral valve boundary 675 defining a mitral valve opening and configured to be surrounded and sutured on the native mitral valve 70, and a pulmonary vein boundary 685 defining an opening for the outlet ostium of the pulmonary vein 130 and configured to be surrounded and sutured corresponding to the outlet ostium of the pulmonary vein 130, respectively. Other embodiments of the left atrial prosthesis may have two or more second openings, the boundaries of the two or more second openings being integrally connected to each other to form two or more pulmonary vein boundaries, the pulmonary vein boundaries defining two or more corresponding openings for the outlet ostia of the pulmonary vein 130, and wherein each of the two or more corresponding openings is configured to surround and suture correspondingly to the outlet ostia of the corresponding pulmonary vein 130.
[0156] Similar to left ventricular prosthesis ( Figure 3 As shown in the figure, the gap 630 is configured to receive a variable amount of fluid, i.e. a liquid, such as a blood-compatible solution, for example a sterile saline solution, or a gas, such as helium, in order to dynamically change the volume of the gap 630 itself and, therefore, the elastically variable volume defined by the inner surface 654 of the internal elastic membrane 650. To this end, the gap 630 can be accessed through (at least) one access hole arranged on the external elastic membrane 600, to which a conduit 360 is sutured after the implantation of the prosthesis in the left atrium, wherein the conduit 360 connects the gap 630 to an external (hydraulic or pneumatic) pump 340B, which is also connected to the gap 230 of the left ventricular prosthesis through the conduit 330; alternatively, the gap 630 can be connected to an external pump separate from the pump to which the gap 230 of the left ventricular prosthesis is connected. Optionally, the boundaries of the (at least one) access hole can be made of a radiopaque material and / or the surgeon can make the access hole in any position on the external elastic membrane 600, similar to the previous description for the invention. Figure 3 The left ventricular prosthesis is shown diagrammatically.
[0157] In particular, for Fig. 9The left atrial prosthesis, with reference to the supporting elastic membrane structure, includes an external elastic membrane 600, a mitral valve boundary 675 operating as an outlet boundary, a native mitral valve 70 operating as a native outlet valve, a pulmonary vein boundary 685 operating as an inlet boundary, an outlet opening of the pulmonary vein 130 operating as an inlet opening of the heart chamber, a gap 630 operating as a main gap, and a plurality of elastic ties 290 operating as a plurality of main variable connecting elements.
[0158] Other embodiments of cardiac chamber prosthesis components intended for the left ventricle 40 and the left atrium 20 may have, instead of or in combination with hydraulic or pneumatic control by (at least) one pump 340B, electric and / or electromagnetic control performed by an electronic processing unit configured to control the electrical and / or electromagnetic polarity of the elastic membranes of the prostheses of the left ventricle 40 and the left atrium 20 provided with electrodes, similar to the control for Figure 6 In this case, gaps 230 and 630 may be filled with a liquid (e.g., a blood-compatible solution) and may be in fluid communication with each other via a communication conduit (instead of or in addition to at least one variable volume elastic bag): during atrial contraction, electrical and / or electromagnetic control increases the volume of gap 630 and decreases the volume of gap 230, thereby moving the liquid from gap 230 to gap 630; during ventricular contraction, electrical and / or electromagnetic control decreases the volume of gap 630 and increases the volume of gap 230, thereby moving the liquid from gap 630 to gap 230. Optionally, such a communication conduit between gap 230 and gap 630 may be sutured by the surgeon after at least one of these gaps has been filled with a liquid during implantation of the prosthesis corresponding to gaps 230 and 630 into the left ventricle 40 and the left atrium 20.
[0159] Other embodiments of the cardiac chamber prosthesis assembly may also include one or more artificial heart valves. By way of example and not limitation, Fig.10 A second embodiment of a cardiac chamber prosthesis assembly intended for use with the left ventricle 40 and the left atrium 20 is shown. Fig. 9 The illustrated cardiac chamber prosthesis assembly differs in that the left atrial prosthesis is provided with an artificial mitral valve 540 integrally coupled to a mitral valve border 675, which defines the mitral valve opening of the prosthesis. This artificial mitral valve 540 allows overcoming the problems caused by an inadequate or pathological native mitral valve, whereby the opening or closing of the mitral valve opening of the prosthesis depends on the opening of the artificial mitral valve 540 (e.g. Fig.10 b, wherein the artificial mitral valve 540 is open (schematically represented by the raised plate beam 545) or closed (as shown in FIG. Fig.10It must be noted that the two prostheses intended for the left ventricle 40 and the left atrium 20 can be connected to each other correspondingly with the respective mitral valve borders 275 and 675, and in this case, the components of the cardiac chamber prosthesis can also be implanted without the mitral valve border 275 and / or the mitral valve border 675 being sutured to the native mitral valve 70.
[0160] Fig.11 A third embodiment of a cardiac chamber prosthesis assembly intended for use with the left ventricle 40, the right ventricle 30, and the right atrium 10 is shown. In particular, the assembly includes Fig. 9 The prosthesis shown is similar to the left ventricular prosthesis and the left atrial prosthesis, as well as the Figure 3 The prosthesis shown is similarly configured as a right ventricular prosthesis implanted in the right ventricle 30. In particular, Fig.11 The right ventricular prosthesis of the illustrated assembly includes an external elastic membrane 700 and an internal elastic membrane 750 elastically connected to each other by means of a plurality of elastic laces 290, the elastic laces 290 defining a closed gap 730 between the external elastic membrane 700 and the internal elastic membrane 750, the gap 730 having a volume configured to be elastically variable, and wherein the external elastic membrane 750 is configured to grasp the inner wall 35 of the right ventricle 30 through a plurality of clamps 210. The external elastic membrane 700 and the internal elastic membrane 750 of the right ventricular prosthesis are provided with a first opening and a second opening, the boundaries of which are integrally coupled to each other to form a pulmonary valve boundary 785 defining a pulmonary valve opening and configured to surround and suture to the native pulmonary valve 60, and a tricuspid valve boundary 775 defining a tricuspid valve opening and configured to surround and suture to the native tricuspid valve 50, respectively.
[0161] In particular, for Fig.11 The right ventricular prosthesis, with reference to the supporting elastic membrane structure, includes an external elastic membrane 700, a pulmonary valve boundary 785 operating as an outlet boundary, a native pulmonary valve 60 operating as a native outlet valve, a tricuspid valve boundary 775 operating as an inlet boundary, a tricuspid valve operating as a natural inlet valve, at least one inlet opening of the heart chamber including a natural inlet valve, a gap 730 operating as a main gap, and a plurality of elastic ligaments 290 operating as a plurality of main variable connecting elements.
[0162] Similar to left ventricular prosthesis ( Figure 3As shown in the figure, the gap 730 is configured to receive a variable amount of fluid, i.e. a liquid, such as a blood-compatible solution, for example a sterile saline solution, or a gas, such as helium, to dynamically change the volume of the gap 730 itself and, therefore, the elastically variable volume defined by the inner surface 754 of the internal elastic membrane 750. To this end, the gap 730 can be accessed through (at least) one access hole arranged on the external elastic membrane 700, to which a conduit 370 is sutured after the prosthesis is implanted in the right atrium, wherein the conduit 370 connects the gap 730 to an external (hydraulic or pneumatic) pump 340C. Optionally, the boundaries of the (at least one) access hole can be made of a radiopaque material and / or the surgeon can make the access hole in any position on the external elastic membrane 700, similar to the previous description for the Figure 3 The left ventricular prosthesis is shown diagrammatically.
[0163] Also in this case, instead of or in combination with hydraulic or pneumatic control, Fig.11 The prosthesis component of can have electrical and / or electromagnetic control performed by an electronic processing unit configured to control the electrical and / or electromagnetic polarity of the internal elastic membrane 750 and the external elastic membrane 700 provided with electrodes. In this case, the gap 730 can be filled with a liquid (e.g., a blood-compatible solution) and can be in fluid communication with (at least) one variable volume elastic bag: during ventricular contraction, the electrical and / or electromagnetic control increases the volume of the gap 730, thereby moving the liquid from the elastic bag to the same gap 730; during atrial contraction, the electrical and / or electromagnetic control decreases the volume of the gap 730, thereby moving the liquid from the gap 730 to the elastic bag.
[0164] also, Fig.11 The prosthetic components may also include one or more artificial heart valves.
[0165] Fig.12 A fourth embodiment of a cardiac chamber prosthesis assembly intended for use with the left ventricle 40, the left atrium 20, the right ventricle 30, and the right atrium 10 is shown. In particular, the assembly includes Fig. 9 A right atrial prosthesis and a left atrial prosthesis similar to the prosthesis shown, and a Fig.11 The prosthesis shown is similar to a right ventricular prosthesis and a right atrial prosthesis configured to be implanted in the right atrium 10. In particular, Fig.12The right atrial prosthesis of the assembly shown includes an outer elastic membrane 800 and an inner elastic membrane 850 elastically connected to each other by means of a plurality of elastic ligaments 290, the elastic ligaments 290 defining a closed gap 830 between the outer elastic membrane 800 and the inner elastic membrane 850, the gap 830 having a volume configured to be elastically variable, and wherein the outer elastic membrane 850 is configured to grasp the inner wall 15 of the atrium 10 via a plurality of clamps 210. The external elastic membrane 800 and the internal elastic membrane 850 of the right atrial prosthesis are provided with a first opening and two second openings, and the boundaries of the first opening and the two second openings are integrally connected to each other to respectively form: a tricuspid valve boundary 885, which defines the tricuspid valve opening and is configured to surround and be sutured on the natural tricuspid valve 50; a superior vena cava boundary 875A, which defines the superior vena cava opening and is configured to surround and be sutured on the outlet of the superior vena cava 120; and an inferior vena cava boundary 875B, which defines the inferior vena cava opening and is configured to surround and be sutured on the outlet of the inferior vena cava 125.
[0166] In particular, for Fig.12 The right atrial prosthesis, with reference to the supporting elastic membrane structure, includes an external elastic membrane 800, a tricuspid valve boundary 885 operating as an outlet boundary, a natural tricuspid valve 50 operating as a natural outlet valve, a superior vena cava boundary 875A and an inferior vena cava boundary 875B operating as inlet boundaries, outlet openings of the superior vena cava 120 and the inferior vena cava 125 operating as inlet openings of the heart chamber, a gap 830 operating as a main gap, and a plurality of elastic ligaments 290 operating as a plurality of main variable connection elements.
[0167] Similar to left ventricular prosthesis ( Figure 3 As shown in the figure, the gap 830 is configured to receive a variable amount of a fluid, which is in particular a liquid, such as a blood-compatible solution, for example a sterile saline solution, or a gas, such as helium, in order to dynamically change the volume of the gap 830 itself and thus the elastically variable volume defined by the inner surface 854 of the internal elastic membrane 850. To this end, the gap 830 can be accessed through (at least) one access hole arranged on the external elastic membrane 800, to which a conduit 380 is sutured after the implantation of the prosthesis in the right atrium, wherein the conduit 380 connects the gap 830 to an external (hydraulic or pneumatic) pump 340D, which is also connected to the gap 730 of the right ventricular prosthesis through a conduit 370; alternatively, the gap 830 can be connected to an external pump separate from the pump to which the gap 730 of the right ventricular prosthesis is connected. Optionally, the boundaries of the (at least one) access hole can be made of a radiopaque material and / or the surgeon can make the access hole in any position on the external elastic membrane 800, similar to the previous description for the invention. Figure 3 The left ventricular prosthesis is shown diagrammatically.
[0168] Also in this case, instead of or in combination with hydraulic or pneumatic control, Fig.12 The prosthesis component of can have electrical and / or electromagnetic control performed by an electronic processing unit configured to control the electrical and / or electromagnetic polarity of the internal elastic membrane 850 and the external elastic membrane 800 provided with electrodes. In this case, the gaps 730 and 830 can be filled with a liquid (e.g., a blood-compatible solution) and can be fluidly connected to each other through a connecting pipe (instead of or together with at least one variable volume elastic bag): during atrial contraction, the electrical and / or electromagnetic control increases the volume of the gap 830 and decreases the volume of the gap 730, thereby moving the liquid from the gap 730 to the gap 830; during ventricular contraction, the electrical and / or electromagnetic control decreases the volume of the gap 830 and increases the volume of the gap 730, thereby moving the liquid from the gap 830 to the gap 730.
[0169] also, Fig.12 The prosthesis assembly may also include one or more artificial heart valves. In this regard, it must be pointed out that, in the case of a prosthesis assembly provided with an artificial tricuspid valve, the two prostheses intended for the right ventricle 30 and the right atrium 10 may be connected to each other with their respective tricuspid valve borders 775 and 885 correspondingly connected, and the assembly of the cardiac chamber prosthesis may also be implanted without the tricuspid valve border 775 and / or the tricuspid valve border 885 being sutured to the natural tricuspid valve 50.
[0170] although Figures 9 to 12 The embodiment of the cardiac chamber prosthesis assembly shown only comprises a prosthesis having only an internal elastic membrane and an external elastic membrane, but it must be pointed out that, instead of or in combination with a two-membrane prosthesis, other embodiments of the cardiac chamber prosthesis assembly according to the invention may even comprise a cardiac chamber prosthesis having an intermediate elastic membrane placed between the internal elastic membrane and the external elastic membrane, similar to the embodiment for Figure 8 The prosthesis shown is illustrated in which the volume change of the gap is controlled by hydraulic or pneumatic control and / or electrical and / or electromagnetic control. For example, in a patient with hypertrophic pathology with enlarged atria, a prosthesis assembly including a left ventricular prosthesis with two membranes and a left atrial prosthesis with three membranes can be implanted.
[0171] It must be pointed out that other embodiments of the cardiac chamber prosthesis according to the invention may include a primary (and secondary) variable connection element, optionally an elastic variable connection element, which connects the membranes to each other, for example a nanotechnological structure configured to present a configuration comprised between a contracted configuration, in which the connected membranes are at a first extreme distance, and an expanded configuration, in which the connected membranes are at a second extreme distance greater than the first extreme distance. As an example, such a nanotechnological structure may include two rods, each of which has its own end connected to a corresponding membrane hinged to each other (optionally in the central region of the rod).
[0172] The cardiac chamber prosthesis and related components according to the present invention can be equipped with sensors (e.g., mechanical sensors, piezoelectric sensors or electrical sensors) on the corresponding elastic membranes, and the sensors are configured to detect pressure changes and electrocardiograms during various stages of the cardiac cycle. In this way, the adjustment of the volume change control of the variable volume gap can be driven to obtain better overall physiological performance. For example, inside the left ventricle, the pressure sensor can allow the control signal to be processed by a technology called PRAM (described in document WO00 / 64339). This processing can be used to determine the time and amplitude of the change of the volume defined by the endothelium in the specific cardiac chamber of the implanted related prosthesis.
[0173] As described above, the cardiac chamber prosthesis and related components according to the present invention are advantageously controlled by hydraulic or pneumatic control and / or electrical and / or electromagnetic control, advantageously by an EPROM-supported memory such as implanted in a pacemaker. This can control one or more prostheses implanted in a corresponding one or more of the four cardiac chambers.
[0174] Preferred embodiments of the present invention have been described above and a number of variations have been proposed, but it should be understood that other variations and modifications may be made by those skilled in the art without departing from the scope of the present invention as defined by the appended claims.
Claims
1. A cardiac chamber prosthesis, the cardiac chamber prosthesis being configured to be implanted in a cardiac chamber (10; 20; 30; 40) of a patient (440), the cardiac chamber (10; 20; 30; 40) being selected from the group consisting of a left ventricle (40), a left atrium (20), a right ventricle (30) and a right atrium (10), in, The heart chamber (10; 20; 30; 40) comprises a natural outlet valve (50; 60; 70; 80) and at least one inlet opening (50; 70) selected from the natural inlet valve (50; 70) and one or more outlet ostia of the vena cava or pulmonary vein (120; 125; 130). 70), Wherein, the cardiac cavity prosthesis comprises: - an internal elastic membrane (250; 255; 260; 650; 750; 850) having an inner surface (254; 654; 754; 854) defining an elastically variable volume, the internal elastic membrane being provided with a first opening defined by respective first boundaries and with at least one second opening defined by respective second boundaries, - a reference supporting elastic membrane structure (200; 205, 225, 290A; 600; 700; 800), the reference supporting elastic membrane structure comprising or consisting of an external elastic membrane (200; 205; 600; 700; 800), the external elastic membrane being provided with a first opening defined by respective first boundaries, and being provided with at least one second opening defined by respective second boundaries, wherein the external elastic membrane (200; 205; 600; 700; 800) is further provided with a plurality of clamps (210) configured to grasp an inner wall (45) of the heart chamber (10; 20; 30; 40), wherein the boundaries of the first openings of the internal elastic membrane and the external elastic membrane (250, 200; 255, 205; 260, 200; 650, 600; 750, 700; 850, 800) are integrally connected to each other to form an outlet boundary (285; 675; 785; 885) configured to surround and suture to the natural outlet valve (50; 60; 70; 80), wherein the boundaries of the second opening of the internal elastic membrane and the external elastic membrane (250, 200; 255, 205; 260, 200; 650, 600; 750, 700; 850, 800) are integrally coupled to each other to form at least one inlet boundary (275; 685; 775; 875A, 875B) configured to surround and sew onto the at least one inlet opening (50; 70), wherein the internal elastic membrane (250; 255; 260; 650; 750; 850) and the reference supporting elastic membrane structure (200; 205, 225, 290A; 600; 700; 800) are connected to each other by means of a plurality of primary variable connecting elements (290; 290B), Thus, the inner elastic membrane (250; 255; 260; 650; 750; 850) and the reference supporting elastic membrane structure (200; 205, 225, 290A; 600; 700; 800) define a main gap (230; 230B; 630; 730; 830) between the inner elastic membrane and the reference supporting elastic membrane structure, and the main gap is configured to receive a fluid with a varying amount and / or pressure to dynamically change the volume of the main gap (230; 230B; 630; 730; 830) and the elastically variable volume defined by the inner surface (254; 654; 754; 854) of the inner elastic membrane (250; 255; 260; 650; 750; 850).
2. The cardiac chamber prosthesis according to claim 1, wherein: The elastic coefficient of the external elastic membrane (200; 205; 600; 700; 800) is not greater than the elastic coefficient of the internal elastic membrane (250; 255; 260; 650; 750; 850).
3. The cardiac chamber prosthesis according to claim 1 or 2, wherein: Each of the inner and outer elastic membranes (250, 200; 255, 205; 260, 200; 650, 600; 750, 700; 850, 800) has a variable elastic coefficient.
4. The cardiac chamber prosthesis according to claim 3, wherein: Each of the internal and external elastic membranes (250, 200; 255, 205; 260, 200; 650, 600; 750, 700; 850, 800) includes two or more regions having corresponding elastic coefficients.
5. The cardiac chamber prosthesis according to claim 1, wherein: The fluid is a liquid, or the fluid is a gas.
6. The cardiac chamber prosthesis according to claim 1 further includes at least one artificial valve (530, 540) integrally connected to the outlet boundary (285; 675; 785; 885) or the at least one inlet boundary (275; 685; 775; 875A, 875B).
7. The cardiac chamber prosthesis according to claim 1, wherein: The main variable connecting elements are main elastic laces (290; 290B), and the elastic coefficient of each main elastic lace is greater than the elastic coefficient of the external elastic membrane (200; 205; 600; 700; 800) and greater than the elastic coefficient of the internal elastic membrane (250; 255; 260; 650; 750; 850).
8. The cardiac chamber prosthesis according to claim 7, wherein: The elastic coefficient of the main elastic lace (290; 290B) can be changed according to the area of the internal elastic membrane (250; 255; 260; 650; 750; 850) to which the main elastic lace is connected.
9. The cardiac chamber prosthesis according to claim 1, wherein the cardiac chamber prosthesis is configured to be accommodated inside a catheter.
10. The cardiac chamber prosthesis according to claim 1, wherein: The external elastic membrane (200; 205; 600; 700; 800) and / or the internal elastic membrane (250; 255; 260; 650; 750; 850) comprises a radiopaque portion.
11. The cardiac chamber prosthesis according to claim 1, wherein: The main gap (230; 230B; 630; 730; 830) is configured to be in fluid communication with at least one variable volume elastic bag provided with the prosthesis or in fluid communication with an external pump (340A; 340B; 340C; 340D).
12. The cardiac chamber prosthesis according to claim 1, wherein: At least one of the internal elastic membrane (260) and the external elastic membrane has a discontinuous structure.
13. The cardiac chamber prosthesis according to claim 12, wherein: The discontinuous structure is a honeycomb-like discontinuous structure formed by a plurality of elastic plates (265) connected to each other along elastic joint lines (267).
14. The cardiac chamber prosthesis according to claim 13, wherein: The elastic coefficient of the elastic joint line (267) is greater than the elastic coefficient of the elastic plate (265).
15. The cardiac chamber prosthesis according to claim 12, wherein: The discontinuous structure is a discontinuous structure formed of a plurality of elastic polygonal plates connected to each other along elastic joint lines.
16. The cardiac chamber prosthesis according to claim 15, wherein: The elastic coefficient of the elastic joint line is greater than the elastic coefficient of the elastic polygonal plate.
17. The cardiac chamber prosthesis according to claim 1, wherein: The inner elastic membrane (250; 255; 260; 650; 750; 850) and the outer elastic membrane (200; 205; 600; 700; 800) are each provided with a plurality of electrodes, and the plurality of electrodes are configured to electrically and / or electromagnetically polarize the inner elastic membrane (250; 255; 260; 650; 750; 850) and the outer elastic membrane (200; 205; 600; 700; 800) respectively under the control of an electronic processing unit (345A; 345B) connected to the electrodes via corresponding control cables (206, 256).
18. The cardiac chamber prosthesis according to claim 1, wherein: The cardiac chamber prosthesis is configured to be implanted: - in the left ventricle (40), whereby the outlet border is an aortic border (285) configured to surround and be sutured to a native aortic valve (80), and the at least one inlet border consists of a mitral valve border (275) configured to surround and be sutured to a native mitral valve (70), or - in the left atrium (20), whereby the outlet border is a mitral valve border (675) configured to surround and suture to a native mitral valve (70), and the at least one inlet border is comprised of one or more pulmonary vein borders (685) configured to surround and suture correspondingly to one or more outlet ostia of a pulmonary vein (130), or - in the right ventricle (30), whereby the outlet border is a pulmonary valve border (785) configured to surround and be sutured to a native pulmonary valve (60), and the at least one inlet border consists of a tricuspid valve border (775) configured to surround and be sutured to a native tricuspid valve (50), or -In the right atrium (10), wherein the outlet boundary is a tricuspid valve boundary (775) configured to surround and suture to a native tricuspid valve (50), and the at least one inlet boundary is composed of one or more vena cava boundaries (875A, 875B) configured to surround and suture corresponding to one or more outlet openings of the vena cava (120, 125).
19. A cardiac chamber prosthesis assembly, comprising two to four cardiac chamber prostheses according to any one of claims 1 to 18, wherein: The cardiac chamber prosthesis is configured to be implanted in corresponding two or more cardiac chambers (10; 20; 30; 40) of a patient (440).
20. The cardiac chamber prosthesis assembly according to claim 19, wherein: The cardiac chamber prosthesis comprises or consists of two cardiac chamber prostheses according to claim 17 which are associated with each other, and the two cardiac chamber prostheses are configured to be implanted in the left ventricle (40) and the left atrium (20), or in the right ventricle (30) and the right atrium (10), wherein the main spaces (230, 630; 730, 830) of the two associated cardiac chamber prostheses are fluidically connected to each other through a connecting pipe, whereby, through the displacement of the fluid between the main spaces (230, 630; 730, 830) of the two associated cardiac chamber prostheses, the volume of the main space (230; 730) of one of the two associated cardiac chamber prostheses is configured to increase when the volume of the main space (630; 830) of the other of the two associated cardiac chamber prostheses decreases, and to decrease when the volume of the main space (630; 830) of the other of the two associated cardiac chamber prostheses increases.
21. A heart assist system comprising: - a cardiac chamber prosthesis according to any one of claims 1 to 18 or a cardiac chamber prosthesis assembly according to claim 19 or 20, - At least one pump (340A; 340B; 340C; 340D) and / or an electronic processing unit (345A; 345B) configured to control the amount and / or pressure of the fluid admitted in the main space (230; 230B; 630; 730; 830) of the cardiac chamber prosthesis or of the cardiac chamber prosthesis component to dynamically change the volume of the main space (230; 230B; 630; 730; 830) of the cardiac chamber prosthesis or of the cardiac chamber prosthesis component.
Citation Information
Patent Citations
Intracardiac implants ("ICI")
CN102271727A
Contraction assisting device for reinforcing contraction force of artificial or regenerated myocardium
JP2010124867A
Prosthetic ventricular heart system
US20160143739A1
Orthotopic intraventricular heart pump
US5139517A
Device and method to limit filling of the heart
US7341584B1
